Phibro Animal Health (PAHC) Inventory Average (2014 - 2026)
Phibro Animal Health's (PAHC) quarterly Inventory Average came in at $528.5 million in Q1 2026, up 20.72% year-on-year from $437.8 million in Q1 2025, and up 6.87% quarter-over-quarter from $494.6 million in Q4 2025.
Phibro Animal Health (PAHC) Inventory Average (2014 - 2026) Analysis & Trends
Phibro Animal Health's Inventory Average history runs 13 years deep, the most recent figure standing at $528.5 million for Q1 2026.
- On a quarterly basis, Inventory Average rose 20.72% year-over-year to $528.5 million in Q1 2026; TTM through Mar 2026 was $528.5 million, a 20.72% increase from a year earlier, with the FY2025 full-year figure at $355.2 million, up 30.7% from the prior year.
- Inventory Average advanced to $528.5 million in Q1 2026 per PAHC's latest filing, from $494.6 million in the prior quarter.
- Across five years, Inventory Average topped out at $528.5 million in Q1 2026 and bottomed at $240.3 million in Q1 2022.
- The 5-year median for Inventory Average is $284.9 million (2022), against an average of $337.1 million.
- Across the five-year window, Inventory Average decreased 3.89% in 2024 and surged 70.15% in 2025, its largest moves.
- Year by year, Inventory Average stood at $284.9 million in 2022, then declined by 0.7% to $282.9 million in 2023, then increased by 23.67% to $349.9 million in 2024, then surged by 41.35% to $494.6 million in 2025, then increased by 6.87% to $528.5 million in 2026.
- Per Business Quant, the three latest PAHC Inventory Average figures stand at $528.5 million (Q1 2026), $494.6 million (Q4 2025), and $458.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 9.02 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 180.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.11 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.96 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 66.75 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.73 Bn |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | 528.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 528.52 Mn |
| Dec 31, 2025 | 494.56 Mn |
| Sep 30, 2025 | 458.10 Mn |
| Jun 30, 2025 | 446.41 Mn |
| Mar 31, 2025 | 437.81 Mn |
| Dec 31, 2024 | 349.89 Mn |
| Sep 30, 2024 | 269.23 Mn |
| Jun 30, 2024 | 274.10 Mn |
| Mar 31, 2024 | 284.48 Mn |
| Dec 31, 2023 | 282.92 Mn |
| Sep 30, 2023 | 278.36 Mn |
| Jun 30, 2023 | 285.20 Mn |
| Mar 31, 2023 | 290.91 Mn |
| Dec 31, 2022 | 284.91 Mn |
| Sep 30, 2022 | 270.00 Mn |
| Jun 30, 2022 | 254.53 Mn |
| Mar 31, 2022 | 240.35 Mn |
| Dec 31, 2021 | 226.05 Mn |
| Sep 30, 2021 | 218.81 Mn |
| Jun 30, 2021 | 211.29 Mn |